Home Stock

Stock Research: Fresenius Medical Care

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Fresenius Medical Care

GER:FME DE0005785802
90
  • Value
    86
  • Growth
    29
  • Safety
    Safety
    84
  • Combined
    80
  • Sentiment
    81
  • 360° View
    360° View
    90
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Fresenius Medical Care AG is a Germany-based kidney dialysis institute providing dialysis care and related services for end-stage renal disease (ESRD) and other extracorporeal therapies. It operates in healthcare services, including R&D, manufacturing, supply chain, and commercial operations, developing both dialysis and non-dialysis products. In the last fiscal year, the company had a market cap of $15757 million, profits of $4925 million, revenue of $20019 million, and 111513 employees.

more

ANALYSIS: With an Obermatt 360° View of 90 (better than 90% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Fresenius Medical Care are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Fresenius Medical Care. The consolidated Value Rank has an attractive rank of 86, which means that the share price of Fresenius Medical Care is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 86% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 84. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 81. But the consolidated Growth Rank has a low rank of 29, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 71 of its competitors have better growth. ...read more

more
Strongest Rank Revenue Growth
Weakest Rank Profit Growth
Country Germany
Industry Health Care Services
Size X-Large
Website freseniusmedicalcare.com
Index
CDAX
DAX 40
Fresenius Medical Care stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
86 88 83 89
Growth
29 38 31 27
Safety
Safety
84 61 74 41
Sentiment
81 58 23 9
360° View
360° View
90 81 54 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
10 13 8 21
Opinions Change
76 65 53 29
Pro Holdings
n/a 51 24 46
Market Pulse
86 81 64 34
Sentiment
81 58 23 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
86 88 83 89
Growth
29 38 31 27
Safety Safety
84 61 74 41
Combined
80 83 82 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
67 69 72 75
Price vs. Earnings (P/E)
72 77 77 89
Price vs. Book (P/B)
72 82 84 84
Dividend Yield
85 77 74 84
Value
86 88 83 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
9 29 10 32
Profit Growth
96 39 8 6
Capital Growth
36 42 82 84
Stock Returns
43 82 83 27
Growth
29 38 31 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
53 31 38 24
Refinancing
71 77 77 47
Liquidity
67 42 42 39
Safety Safety
84 61 74 41

Similar Stocks

Discover high‑ranked alternatives to Fresenius Medical Care and broaden your portfolio horizons.

Volkswagen VW

GER:VOW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Hornbach Holding

GER:HBH
Country: Germany
Industry: Home Improvement Retail
Size: Large
Full Stock Analysis

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Mercedes-Benz

GER:MBG
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews